BESSEMER GROUP INC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$6,765,000
-46.1%
357,5770.0%0.01%
-44.0%
Q4 2021$12,544,000
-4.2%
357,5770.0%0.02%
-10.7%
Q3 2021$13,091,000
-6.8%
357,5770.0%0.03%
-6.7%
Q2 2021$14,042,000
+38.8%
357,577
-0.1%
0.03%
+25.0%
Q1 2021$10,115,000
+14.7%
358,028
+30.0%
0.02%
+4.3%
Q4 2020$8,817,000
-0.9%
275,3460.0%0.02%
-11.5%
Q3 2020$8,894,000275,3460.03%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2022
NameSharesValueWeighting ↓
INDUS CAPITAL PARTNERS, LLC 1,304,603$15,525,0001.47%
Prudence Asset Management Ltd 37,148$442,0000.33%
Prince Street Capital Management LLC 87,700$1,044,0000.19%
PRUDENTIAL PLC 1,306,437$15,599,0000.06%
Folger Hill Asset Management LP 60,950$725,0000.04%
SCHRODER INVESTMENT MANAGEMENT GROUP 624,543$7,457,0000.01%
Pine River Capital Management L.P. 28,641$341,0000.01%
Sumitomo Mitsui Trust Holdings, Inc. 209,420$2,492,0000.00%
Allianz Asset Management GmbH 299,200$3,560,0000.00%
Baillie Gifford 152,926$1,826,0000.00%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders